Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS)
CNY 220.76
(0.79%)
CNY 220.76
(0.79%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.59 Billion CNY | 13.87% |
| 2022 | 3.96 Billion CNY | -2.47% |
| 2021 | 4.06 Billion CNY | 38.38% |
| 2020 | 2.94 Billion CNY | 16.15% |
| 2019 | 2.53 Billion CNY | 25.2% |
| 2018 | 2.02 Billion CNY | 25.83% |
| 2017 | 1.6 Billion CNY | 42.17% |
| 2016 | 1.13 Billion CNY | 27.5% |
| 2015 | 886.36 Million CNY | 22.14% |
| 2014 | 725.71 Million CNY | -4.73% |
| 2013 | 761.71 Million CNY | 22.89% |
| 2012 | 619.82 Million CNY | 33.25% |
| 2011 | 465.17 Million CNY | 39.17% |
| 2010 | 334.23 Million CNY | 26.44% |
| 2009 | 264.34 Million CNY | 9.45% |
| 2008 | 241.52 Million CNY | 10.77% |
| 2007 | 218.03 Million CNY | 14.84% |
| 2006 | 189.86 Million CNY | -6.79% |
| 2005 | 203.69 Million CNY | 19.5% |
| 2004 | 170.45 Million CNY | 19.06% |
| 2003 | 143.17 Million CNY | 4.09% |
| 2002 | 137.54 Million CNY | 11.81% |
| 2001 | 123 Million CNY | 3.93% |
| 2000 | 118.36 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 1.31 Billion CNY | 135.31% |
| 2024 Q2 | 557.66 Million CNY | -62.19% |
| 2024 Q1 | 1.47 Billion CNY | 50.7% |
| 2023 Q2 | 1.1 Billion CNY | -13.01% |
| 2023 Q3 | 1.3 Billion CNY | 18.36% |
| 2023 FY | 4.51 Billion CNY | 13.87% |
| 2023 Q1 | 1.27 Billion CNY | 55.67% |
| 2023 Q4 | 978.66 Million CNY | -25.16% |
| 2022 FY | 3.96 Billion CNY | -2.47% |
| 2022 Q4 | 815.84 Million CNY | -21.77% |
| 2022 Q1 | 1.15 Billion CNY | 38.55% |
| 2022 Q2 | 957.55 Million CNY | -16.87% |
| 2022 Q3 | 1.04 Billion CNY | 8.91% |
| 2021 FY | 4.06 Billion CNY | 38.38% |
| 2021 Q1 | 966.36 Million CNY | 79.09% |
| 2021 Q4 | 831.33 Million CNY | -37.04% |
| 2021 Q3 | 1.32 Billion CNY | 38.92% |
| 2021 Q2 | 950.46 Million CNY | -1.65% |
| 2020 Q2 | 680.66 Million CNY | -17.26% |
| 2020 Q3 | 897.27 Million CNY | 31.82% |
| 2020 Q4 | 539.6 Million CNY | -39.86% |
| 2020 FY | 2.94 Billion CNY | 16.15% |
| 2020 Q1 | 822.66 Million CNY | 39.91% |
| 2019 Q4 | 588.01 Million CNY | -8.83% |
| 2019 Q3 | 644.94 Million CNY | 4.89% |
| 2019 FY | 2.53 Billion CNY | 25.2% |
| 2019 Q1 | 683.46 Million CNY | 51.69% |
| 2019 Q2 | 614.9 Million CNY | -10.03% |
| 2018 FY | 2.02 Billion CNY | 25.83% |
| 2018 Q1 | 568.14 Million CNY | 34.98% |
| 2018 Q3 | 499.26 Million CNY | -0.91% |
| 2018 Q4 | 450.56 Million CNY | -9.75% |
| 2018 Q2 | 503.82 Million CNY | -11.32% |
| 2017 Q1 | 385.21 Million CNY | 59.7% |
| 2017 Q4 | 420.9 Million CNY | 1.94% |
| 2017 Q2 | 387.72 Million CNY | 0.65% |
| 2017 FY | 1.6 Billion CNY | 42.17% |
| 2017 Q3 | 412.91 Million CNY | 6.5% |
| 2016 Q1 | 274.28 Million CNY | 20.98% |
| 2016 Q4 | 241.2 Million CNY | -24.72% |
| 2016 Q3 | 320.43 Million CNY | 8.91% |
| 2016 Q2 | 294.2 Million CNY | 7.26% |
| 2016 FY | 1.13 Billion CNY | 27.5% |
| 2015 Q2 | 208.61 Million CNY | -5.43% |
| 2015 FY | 886.36 Million CNY | 22.14% |
| 2015 Q4 | 226.72 Million CNY | -1.62% |
| 2015 Q3 | 230.45 Million CNY | 10.47% |
| 2015 Q1 | 220.57 Million CNY | 13.92% |
| 2014 Q4 | 193.61 Million CNY | 22.23% |
| 2014 FY | 725.71 Million CNY | -4.73% |
| 2014 Q1 | 202.73 Million CNY | 14.35% |
| 2014 Q3 | 158.4 Million CNY | -7.34% |
| 2014 Q2 | 170.95 Million CNY | -15.68% |
| 2013 Q1 | 189.95 Million CNY | 30.88% |
| 2013 Q2 | 190.44 Million CNY | 0.26% |
| 2013 Q3 | 204.02 Million CNY | 7.13% |
| 2013 Q4 | 177.29 Million CNY | -13.1% |
| 2013 FY | 761.71 Million CNY | 22.89% |
| 2012 Q4 | 145.13 Million CNY | -11.6% |
| 2012 Q3 | 164.17 Million CNY | 6.14% |
| 2012 Q2 | 154.67 Million CNY | -0.75% |
| 2012 Q1 | 155.84 Million CNY | 34.07% |
| 2012 FY | 619.82 Million CNY | 33.25% |
| 2011 Q4 | 116.23 Million CNY | -5.46% |
| 2011 FY | 465.17 Million CNY | 39.17% |
| 2011 Q3 | 122.95 Million CNY | 15.74% |
| 2011 Q2 | 106.23 Million CNY | -11.28% |
| 2011 Q1 | 119.74 Million CNY | 46.2% |
| 2010 FY | 334.23 Million CNY | 26.44% |
| 2010 Q3 | 88.44 Million CNY | -8.9% |
| 2010 Q2 | 97.08 Million CNY | 45.34% |
| 2010 Q4 | 81.9 Million CNY | -7.39% |
| 2010 Q1 | 66.79 Million CNY | 3.0% |
| 2009 Q4 | 64.85 Million CNY | -6.53% |
| 2009 Q2 | 76.65 Million CNY | 43.41% |
| 2009 Q1 | 53.45 Million CNY | -14.33% |
| 2009 Q3 | 69.38 Million CNY | -9.49% |
| 2009 FY | 264.34 Million CNY | 9.45% |
| 2008 Q3 | 61.75 Million CNY | 12.65% |
| 2008 Q4 | 62.39 Million CNY | 1.04% |
| 2008 FY | 241.52 Million CNY | 10.77% |
| 2008 Q1 | 62.55 Million CNY | 19.64% |
| 2008 Q2 | 54.82 Million CNY | -12.36% |
| 2007 Q4 | 52.28 Million CNY | -0.02% |
| 2007 Q3 | 52.29 Million CNY | -7.67% |
| 2007 Q2 | 56.63 Million CNY | -0.35% |
| 2007 Q1 | 56.83 Million CNY | 28.27% |
| 2007 FY | 218.03 Million CNY | 14.84% |
| 2006 Q3 | 51.43 Million CNY | -7.67% |
| 2006 Q4 | 44.3 Million CNY | -13.86% |
| 2006 Q2 | 55.7 Million CNY | 44.99% |
| 2006 FY | 189.86 Million CNY | -6.79% |
| 2006 Q1 | 38.42 Million CNY | -28.01% |
| 2005 FY | 203.69 Million CNY | 19.5% |
| 2005 Q4 | 53.37 Million CNY | -14.19% |
| 2005 Q3 | 62.2 Million CNY | 13.78% |
| 2005 Q2 | 54.66 Million CNY | 63.4% |
| 2005 Q1 | 33.45 Million CNY | -35.89% |
| 2004 Q4 | 52.18 Million CNY | 23.87% |
| 2004 Q2 | 56.72 Million CNY | 192.1% |
| 2004 FY | 170.45 Million CNY | 19.06% |
| 2004 Q1 | 19.41 Million CNY | -59.93% |
| 2004 Q3 | 42.13 Million CNY | -25.73% |
| 2003 Q3 | 28.81 Million CNY | -16.56% |
| 2003 Q2 | 34.54 Million CNY | 10.18% |
| 2003 Q4 | 48.46 Million CNY | 68.16% |
| 2003 FY | 143.17 Million CNY | 4.09% |
| 2003 Q1 | 31.34 Million CNY | -29.84% |
| 2002 FY | 137.54 Million CNY | 11.81% |
| 2002 Q4 | 44.67 Million CNY | 30.43% |
| 2002 Q3 | 34.25 Million CNY | 0.0% |
| 2001 FY | 123 Million CNY | 3.93% |
| 2000 FY | 118.36 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 19.29 Billion CNY | 76.164% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.89 Billion CNY | -18.008% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 1.13 Billion CNY | -303.85% |
| Aurora Optoelectronics Co.,Ltd. | -319.56 Million CNY | 1539.177% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 23.41 Million CNY | -19543.462% |
| NanJing Pharmaceutical Company Limited | 3.31 Billion CNY | -38.808% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 936.59 Million CNY | -391.047% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 2.45 Billion CNY | -87.386% |